Interneuron Diversity series: Interneuronal neuropeptides - Endogenous regulators of neuronal excitability

Trends in Neurosciences

Volumn 27, Issue 3, 2004, Pages 135-142

  Baraban, Scott C ^a   Tallent, Melanie K ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BIOCHEMICAL MARKER; CHOLECYSTOKININ; CORTISTATIN; GALANIN; GALANIN 1 RECEPTOR AGONIST; NEUROPEPTIDE; NEUROPEPTIDE Y; NOCICEPTIN; SOMATOSTATIN; SUBSTANCE P; UNCLASSIFIED DRUG;

BRAIN FUNCTION; COGNITION; DRUG EFFICACY; EPILEPSY; HUMAN; INTERNEURON; LEARNING; NERVE CELL EXCITABILITY; NERVE CELL MEMBRANE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; REVIEW; SYNAPTIC INHIBITION;

EID: 1342321781     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tins.2004.01.008     Document Type: Review

References (93)

1. Klausberger T., et al. Brain-state- and cell-type-specific firing of hippocampal interneurons in vivo. Nature. 421:2003;844-848.
2. Lacaille J.C., Williams S. Membrane properties of interneurons in stratum oriens-alveus of the CA1 region of rat hippocampus in vitro. Neuroscience. 36:1990;349-359.
3. Velazquez J.L., Carlen P.L. Synchronization of GABAergic interneuronal networks during seizure-like activity in the rat horizontal hippocampal slice. Eur. J. Neurosci. 11:1999;4110-4118.
4. Pitler T.A., Alger B.E. Cholinergic excitation of GABAergic interneurons in the rat hippocampal slice. J. Physiol. 450:1992;127-142.
5. Bergles D., et al. Excitatory actions of norepinephrine on multiple classes of hippocampal CA1 interneurons. J. Neurosci. 16:1996;572-585.
6. Baraban S.C., et al. Knock-out mice reveal a critical antiepileptic role for neuropeptide Y. J. Neurosci. 17:1997;8927-8936.
7. 5 neuropeptide Y receptor in limbic seizures. Proc. Natl. Acad. Sci. U. S. A. 96:1999;13518-13523.
8. Cherubini E., North R.A. Mu and kappa opioids inhibit transmitter release by different mechanisms. Proc. Natl. Acad. Sci. U. S. A. 82:1985;1860-1863.
9. Whittaker E., et al. Neuropeptide Y inhibits glutamate release and long-term potentiation in rat dentate gyrus. Brain Res. 827:1999;229-233.
10. Tallent M.K., et al. Nociceptin reduces epileptiform events in CA3 hippocampus via presynaptic and postsynaptic mechanisms. J. Neurosci. 21:2001;6940-6948.
11. 2 receptors inhibit the frequency of spontaneous but not miniature EPSCs in CA3 pyramidal cells of rat hippocampus. J. Neurophysiol. 76:1996;3159-3168.
12. 5 receptors mediate neuropeptide Y actions at excitatory synapses in area CA3 of the mouse hippocampus. J. Neurophysiol. 87:2002;558-566.
13. Kandel E.R. The molecular biology of memory storage: a dialogue between genes and synapses. Science. 294:2001;1030-1038.
14. 2+ signaling in mouse dentate gyrus. J. Neurophysiol. 88:2002;3078-3086.
15. Deller T., Leranth C. Synaptic connections of neuropeptide Y (NPY) immunoreactive neurons in the hilar area of the rat hippocampus. J. Comp. Neurol. 300:1990;433-447.
16. Katona I., et al. Postsynaptic targets of somatostatin-immunoreactive interneurons in the rat hippocampus. Neuroscience. 88:1999;37-55.
17. 2A receptors and somatostatin-containing axons in rat brain: evidence for regulation of cell surface receptors by endogenous somatostatin. J. Neurosci. 18:1998;1056-1071.
18. Sun Q.Q., et al. Target-specific neuropeptide Y-ergic synaptic inhibition and its network consequences within the mammalian thalamus. J. Neurosci. 23:2003;9639-9649.
19. McQuiston A.R., Colmers W.F. Neuropeptide Y does not alter NMDA conductances in CA3 pyramidal neurons: a slice-patch study. Neurosci. Lett. 138:1992;261-264.
20. Sun Q.Q., et al. Somatostatin inhibits thalamic network oscillations in vitro: actions on the GABAergic neurons of the reticular nucleus. J. Neurosci. 22:2002;5374-5386.
21. Nakazawa K., et al. Requirement for hippocampal CA3 NMDA receptors in associative memory recall. Science. 297:2002;211-218.
22. Yu T.P., et al. Orphanin FQ inhibits synaptic transmission and long-term potentiation in rat hippocampus. Hippocampus. 7:1997;88-94.
23. Yu T.P., Xie C.W. Orphanin FQ/nociceptin inhibits synaptic transmission and long-term potentiation in rat dentate gyrus through postsynaptic mechanisms. J. Neurophysiol. 80:1998;1277-1284.
24. Nicoll R.A. The action of thyrotropin-releasing hormone, substance P and related peptides on frog spinal motoneurons. J. Pharmacol. Exp. Ther. 207:1978;817-824.
25. Klapstein G.J., Colmers W.F. On the sites of presynaptic inhibition by neuropeptide Y in rat hippocampus in vitro. Hippocampus. 3:1993;103-111.
26. Sakurai E., et al. Galanin inhibits long-term potentiation at Schaffer collateral-CA1 synapses in guinea-pig hippocampal slices. Neurosci. Lett. 212:1996;21-24.
27. Tallent M.K., Siggins G.R. Somatostatin depresses excitatory but not inhibitory neurotransmission in rat CA1 hippocampus. J. Neurophysiol. 78:1997;3008-3018.
28. Weisskopf M.G., et al. The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fibre synapses and modulates long-term potentiation. Nature. 362:1993;423-427.
29. Tallent M.K., Siggins G.R. Somatostatin acts in CA1 and CA3 to reduce hippocampal epileptiform activity. J. Neurophysiol. 81:1999;1626-1635.
30. Moore S.D., et al. Voltage-dependent effects of opioid peptides on hippocampal CA3 pyramidal neurons in vitro. J. Neurosci. 14:1994;809-820.
31. Colmers W.F., et al. Neuropeptide Y action in the rat hippocampal slice: site and mechanism of presynaptic inhibition. J. Neurosci. 8:1988;3827-3837.
32. Meis S., et al. Antioscillatory effects of nociceptin/orphanin FQ in synaptic networks of the rat thalamus. J. Neurosci. 22:2002;718-727.
33. Meis S., Pape H.C. Control of glutamate and GABA release by nociceptin/orphanin FQ in the rat lateral amygdala. J. Physiol. 532:2001;701-712.
34. Bacci A., et al. Differential modulation of synaptic transmission by neuropeptide Y in rat neocortical neurons. Proc. Natl. Acad. Sci. U. S. A. 99:2002;17125-17130.
35. Greene J.R.T., Mason A. Effects of somatostatin and related peptides on the membrane potential and input resistance of rat ventral subicular neurons, in vitro. J. Pharmacol. Exp. Ther. 276:1996;426-432.
36. Lupica C.R., et al. Dissociation of mu and delta opioid receptor-mediated reductions in evoked and spontaneous synaptic inhibition in the rat hippocampus in vitro. Brain Res. 593:1992;226-238.
37. Stocca G., Nistri A. The neuropeptide thyrotropin-releasing hormone modulates GABAergic synaptic transmission on pyramidal neurones of the rat hippocampal slice. Peptides. 17:1996;1197-1202.
38. Miller K.K., Lupica C.R. Neuropeptide FF inhibition of morphine effects in the rat hippocampus. Brain Res. 750:1997;81-86.
39. Jan Y.N., et al. A peptide as a possible transmitter in sympathetic ganglia of the frog. Proc. Natl. Acad. Sci. U. S. A. 76:1979;1501-1505.
40. Dodd J., Kelly J.S. Is somatostatin an excitatory neurotransmitter in the hippocampus? Nature. 273:1978;674-675.
41. Pittman Q.J., Siggins G.R. Somatostatin hyperpolarizes pyramidal cells in vitro. Brain Res. 221:1981;402-408.
42. Moore S.D., et al. Somatostatin augments the M-current in hippocampal neurons. Science. 239:1988;278-280.
43. + conductance in rat CA1 hippocampal neurons. J. Neurophysiol. 79:1998;1230-1238.
44. Schweitzer P., et al. The sleep-modulating peptide cortistatin augments the h-current in hippocampal neurons. J. Neurosci. 23:2003;10884-10891.
45. + current in rat hippocampal pyramidal cells. J. Physiol. 545:2002;783-805.
46. 2+ channels in freshly dissociated rat hippocampal neurons. J. Neurophysiol. 74:1995;1028-1036.
47. 2+ entry. J. Neurosci. 17:1997;8169-8177.
48. 2+ channels in rat thalamic neurons. J. Physiol. 531:2001;67-79.
49. Paredes M.F., et al. Neuropeptide Y modulates a G protein-coupled inwardly rectifying potassium current in the mouse hippocampus. Neurosci. Lett. 340:2003;9-12.
50. Neal C.R. Jr, et al. Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J. Comp. Neurol. 406:1999;503-547.
51. Ikeda K., et al. Distribution of prepro-nociceptin/orphanin FQ mRNA and its receptor mRNA in developing and adult mouse central nervous systems. J. Comp. Neurol. 399:1998;139-151.
52. Neal C.R. Jr, et al. Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding. J. Comp. Neurol. 412:1999;563-605.
53. Manabe T., et al. Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors. Nature. 394:1998;577-581.
54. Higgins G.A., et al. A combined pharmacological and genetic approach to investigate the role of orphanin FQ in learning and memory. Eur. J. Neurosci. 15:2002;911-922.
55. Dutar P., et al. Spatial learning and synaptic hippocampal plasticity in type 2 somatostatin receptor knock-out mice. Neuroscience. 112:2002;455-466.
56. Vecsei L., Klivenyi P. Somatostatin and Alzheimer's disease. Arch. Gerontol. Geriatr. 21:1995;35-41.
57. Lamirault L., et al. Intrahippocampal injections of somatostatin dissociate acquisition from the flexible use of place responses. Eur. J. Neurosci. 14:2001;567-570.
58. McHugh T.J., et al. Impaired hippocampal representation of space in CA1-specific NMDAR1 knockout mice. Cell. 87:1996;1339-1349.
59. Radulovic J., et al. Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2. J. Neurosci. 19:1999;5016-5025.
60. Aldenhoff J.B., et al. Corticotropin releasing factor decreases postburst hyperpolarizations and excites hippocampal neurons. Science. 221:1983;875-877.
61. Blank T., et al. Corticotropin-releasing factor receptors couple to multiple G-proteins to activate diverse intracellular signaling pathways in mouse hippocampus: role in neuronal excitability and associative learning. J. Neurosci. 23:2003;700-707.
62. Nilsson L., et al. Environmental influence on somatostatin levels and gene expression in the rat brain. Brain Res. 628:1993;93-98.
63. Dournaud P., et al. Correlations between water maze performance and cortical somatostatin mRNA and high-affinity binding sites during ageing in rats. Eur. J. Neurosci. 8:1996;476-485.
64. Davies P., et al. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementia. Nature. 288:1980;279-280.
65. Davis K.L., et al. Neuropeptide abnormalities in patients with early Alzheimer disease. Arch. Gen. Psychiatry. 56:1999;981-987.
66. Sundstrom L.E., et al. Somatostatin- and neuropeptide Y-synthesizing neurones in the fascia dentata of humans with temporal lobe epilepsy. Brain. 124:2001;688-697.
67. de Lanerolle N.C., et al. A retrospective analysis of hippocampal pathology in human temporal lobe epilepsy: evidence for distinctive patient subcategories. Epilepsia. 44:2003;677-687.
68. Sperk G., et al. Functional changes in neuropeptide Y- and somatostatin-containing neurons induced by limbic seizures in the rat. Neuroscience. 50:1992;831-846.
69. Bendotti C., et al. Increased expression of GAP-43, somatostatin and neuropeptide Y mRNA in the hippocampus during development of hippocampal kindling in rats. Eur. J. Neurosci. 5:1993;1312-1320.
70. Zhang L.X., et al. Changes in cholecystokinin mRNA expression after amygdala kindled seizures: an in situ hybridization study. Brain Res. Mol. Brain Res. 35:1996;278-284.
71. Lurton D., Cavalheiro E.A. Neuropeptide-Y immunoreactivity in the pilocarpine model of temporal lobe epilepsy. Exp. Brain Res. 116:1997;186-190.
72. Vezzani A., Hoyer D. Brain somatostatin: a candidate inhibitory role in seizures and epileptogenesis. Eur. J. Neurosci. 11:1999;3767-3776.
73. Buckmaster P.S., et al. Heightened seizure severity in somatostatin knockout mice. Epilepsy Res. 48:2002;43-56.
74. Gutierrez R., et al. Orphanin-FQ/nociceptin inhibits kindling epileptogenesis and enhances hippocampal feed-forward inhibition. Neuroscience. 105:2001;325-333.
75. Rubaj A., et al. Nociceptin, OP4 receptor ligand in different models of experimental epilepsy. Peptides. 23:2002;497-505.
76. Mazarati A.M., et al. Modulation of hippocampal excitability and seizures by galanin. J. Neurosci. 20:2000;6276-6281.
77. Kokaia M., et al. Suppressed kindling epileptogenesis in mice with ectopic overexpression of galanin. Proc. Natl. Acad. Sci. U. S. A. 98:2001;14006-14011.
78. Haberman R.P., et al. Attenuation of seizures and neuronal death by adeno-associated virus vector galanin expression and secretion. Nat. Med. 9:2003;1076-1080.
79. Klapstein G.J., Colmers W.F. Neuropeptide Y suppresses epileptiform activity in rat hippocampus in vitro. J. Neurophysiol. 78:1997;1651-1661.
80. Saar K., et al. Anticonvulsant activity of a nonpeptide galanin receptor agonist. Proc. Natl. Acad. Sci. U. S. A. 99:2002;7136-7141.
81. Jacoby A.S., et al. Critical role for GALR1 galanin receptor in galanin regulation of neuroendocrine function and seizure activity. Brain Res. Mol. Brain Res. 107:2002;195-200.
82. + currents in epileptiform bursting and antiepileptic actions of nociceptin in rat CA3 hippocampus. Soc. Neurosci. Abstr. 27:2001;. Program No. 147.3.
83. Videau C., et al. Characterisation of [125I]-Tyr0DTrp8-somatostatin binding in sst1- to sst4- and SRIF-gene-invalidated mouse brain. Naunyn Schmiedebergs Arch. Pharmacol. 367:2003;562-571.
84. Ludwig M., Pittman Q.J. Talking back: dendritic neurotransmitter release. Trends Neurosci. 26:2003;255-261.
85. Ludwig M., et al. Intracellular calcium stores regulate activity-dependent neuropeptide release from dendrites. Nature. 418:2002;85-89.
86. Kits K.S., Mansvelder H.D. Regulation of exocytosis in neuroendocrine cells: spatial organization of channels and vesicles, stimulus-secretion coupling, calcium buffers and modulation. Brain Res. Brain Res. Rev. 33:2000;78-94.
87. Edwards R.H. Neurotransmitter release: variations on a theme. Curr. Biol. 8:1998;R883-R885.
88. Barg S., et al. Delay between fusion pore opening and peptide release from large dense-core vesicles in neuroendocrine cells. Neuron. 33:2002;287-299.
89. Erickson J.C., et al. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature. 381:1996;415-421.
90. 1 receptors. Eur. J. Neurosci. 10:1998;757-759.
91. Leroux P., et al. Quantitative autoradiography of somatostatin receptors in the rat limbic system. J. Comp. Neurol. 331:1993;389-401.
92. Boehm S., Betz H. Somatostatin inhibits excitatory transmission at rat hippocampal synapses via presynaptic receptors. J. Neurosci. 17:1997;4066-4075.
93. Takagi H. Roles of ion channels in EPSP integration at neuronal dendrites. Neurosci. Res. 37:2000;167-171.